Table of Content

1. Introduction

1.1 The Insight Partners Research Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

2.2 North America Infectious Disease Diagnostics Market, by Country (US$ Million)

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. North America Infectious Disease Diagnostics Market - Key Industry Dynamics

4.1 Market Drivers:

4.1.1 Rising Incidence of Infectious Diseases

4.1.2 Rising Application of Diagnostics in Veterinary Infectious Disease

4.2 Market Restraints

4.2.1 Inadequate Reimbursement Scenario

4.3 Market Opportunities

4.3.1 Increasing Focus on R&D and Funding in Infectious Disease Diagnostics

4.4 Future Trends

4.4.1 Rising Number of Product Approvals and Launches

4.5 Impact Analysis:

5. Infectious Disease Diagnostics Market - North America Market Analysis

5.1 North America Infectious Disease Diagnostics Market Revenue (US$ Mn), 2022 - 2030

6. North America Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 - by Product

6.1 Overview

6.2 North America Infectious Disease Diagnostics Market Revenue Share, by Product, 2022 & 2030 (%)

6.3 Kits & Reagents

6.3.1 Overview

6.3.2 Kits & Reagents: North America Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)

6.4 Instruments

6.4.1 Overview

6.4.2 Instruments: North America Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)

6.5 Software & Services

6.5.1 Overview

6.5.2 Software & Services: North America Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)

7. North America Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 - by Technology

7.1 Overview

7.2 North America Infectious Disease Diagnostics Market Revenue Share, by Technology, 2022 & 2030 (%)

7.3 Biosensor-based

7.3.1 Overview

7.3.2 Biosensor-based: North America Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)

7.4 Immunodiagnostics

7.4.1 Overview

7.4.2 Immunodiagnostics: North America Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)

7.4.2.1 North America Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020-2030 (US$ Million)

7.5 Molecular-Based Diagnostic Techniques

7.5.1 Overview

7.5.2 Molecular-Based Diagnostic Techniques: North America Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)

7.5.2.1 North America Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020-2030 (US$ Million)

7.6 Clinical Biology

7.6.1 Overview

7.6.2 Clinical Biology: North America Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)

7.7 Others

7.7.1 Overview

7.7.2 Others: North America Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)

8. North America Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 - by Application Type

8.1 Overview

8.2 North America Infectious Disease Diagnostics Market Revenue Share, by Application Type, 2022 & 2030 (%)

8.3 Point-of-Care Testing

8.3.1 Overview

8.3.2 Point-of-Care Testing: North America Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)

8.4 Laboratory Testing

8.4.1 Overview

8.4.2 Laboratory Testing: North America Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)

9. North America Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 - by Testing Type

9.1 Overview

9.2 North America Infectious Disease Diagnostics Market Revenue Share, by Testing Type, 2022 & 2030 (%)

9.3 Human Testing

9.3.1 Overview

9.3.2 Human Testing: North America Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)

9.3.2.1 North America Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020-2030 (US$ Million)

9.4 Veterinary Testing

9.4.1 Overview

9.4.2 Veterinary Testing: North America Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)

10. North America Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 - by End User

10.1 Overview

10.2 North America Infectious Disease Diagnostics Market Revenue Share, by End User, 2022 & 2030 (%)

10.3 Diagnostic Laboratories

10.3.1 Overview

10.3.2 Diagnostic Laboratories: North America Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)

10.4 Hospitals and Clinics

10.4.1 Overview

10.4.2 Hospitals and Clinics: North America Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)

10.5 Research Institutes

10.5.1 Overview

10.5.2 Research Institutes: North America Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)

10.6 Homecare Settings

10.6.1 Overview

10.6.2 Homecare Settings: North America Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)

10.7 Others

10.7.1 Overview

10.7.2 Others: North America Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)

11. North America Infectious Disease Diagnostics Market - Country Analysis

11.1 North America Infectious Disease Diagnostics Market - Country Analysis

11.1.1 North America Infectious Disease Diagnostics Market, by Country

11.1.1.1 US

11.1.1.1.1 Overview

11.1.1.1.2 US: North America Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)

11.1.1.1.3 US: North America Infectious Disease Diagnostics Market, by Product, 2020-2030 (US$ Million)

11.1.1.1.4 US: North America Infectious Disease Diagnostics Market, by Technology, 2020-2030 (US$ Million)

11.1.1.1.4.1 US: North America Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020-2030 (US$ Million)

11.1.1.1.4.2 US: North America Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020-2030 (US$ Million)

11.1.1.1.5 US: North America Infectious Disease Diagnostics Market, by Application Type, 2020-2030 (US$ Million)

11.1.1.1.6 US: North America Infectious Disease Diagnostics Market, by Testing Type, 2020-2030 (US$ Million)

11.1.1.1.6.1 US: North America Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020-2030 (US$ Million)

11.1.1.1.7 US: North America Infectious Disease Diagnostics Market, by End User, 2020-2030 (US$ Million)

11.1.1.2 Canada

11.1.1.2.1 Overview

11.1.1.2.2 Canada: North America Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)

11.1.1.2.3 Canada: North America Infectious Disease Diagnostics Market, by Product, 2020-2030 (US$ Million)

11.1.1.2.4 Canada: North America Infectious Disease Diagnostics Market, by Technology, 2020-2030 (US$ Million)

11.1.1.2.4.1 Canada: North America Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020-2030 (US$ Million)

11.1.1.2.4.2 Canada: North America Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020-2030 (US$ Million)

11.1.1.2.5 Canada: North America Infectious Disease Diagnostics Market, by Application Type, 2020-2030 (US$ Million)

11.1.1.2.6 Canada: North America Infectious Disease Diagnostics Market, by Testing Type, 2020-2030 (US$ Million)

11.1.1.2.6.1 Canada: North America Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020-2030 (US$ Million)

11.1.1.2.7 Canada: North America Infectious Disease Diagnostics Market, by End User, 2020-2030 (US$ Million)

11.1.1.3 Mexico

11.1.1.3.1 Overview

11.1.1.3.2 Mexico: North America Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)

11.1.1.3.3 Mexico: North America Infectious Disease Diagnostics Market, by Product, 2020-2030 (US$ Million)

11.1.1.3.4 Mexico: North America Infectious Disease Diagnostics Market, by Technology, 2020-2030 (US$ Million)

11.1.1.3.4.1 Mexico: North America Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020-2030 (US$ Million)

11.1.1.3.4.2 Mexico: North America Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020-2030 (US$ Million)

11.1.1.3.5 Mexico: North America Infectious Disease Diagnostics Market, by Application Type, 2020-2030 (US$ Million)

11.1.1.3.6 Mexico: North America Infectious Disease Diagnostics Market, by Testing Type, 2020-2030 (US$ Million)

11.1.1.3.6.1 Mexico: North America Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020-2030 (US$ Million)

11.1.1.3.7 Mexico: North America Infectious Disease Diagnostics Market, by End User, 2020-2030 (US$ Million)

12. Industry Landscape

12.1 Overview

12.2 Growth Strategies Done by the Companies in the Market, (%)

12.3 Organic Developments

12.3.1 Overview

12.4 Inorganic Developments

12.4.1 Overview

13. Company Profiles

13.1 Abbott Laboratories

13.1.1 Key Facts

13.1.2 Business Description

13.1.3 Products and Services

13.1.4 Financial Overview

13.1.5 SWOT Analysis

13.1.6 Key Developments

13.2 Bruker Corp

13.2.1 Key Facts

13.2.2 Business Description

13.2.3 Products and Services

13.2.4 Financial Overview

13.2.5 SWOT Analysis

13.2.6 Key Developments

13.3 Cardinal Health Inc

13.3.1 Key Facts

13.3.2 Business Description

13.3.3 Products and Services

13.3.4 Financial Overview

13.3.5 SWOT Analysis

13.3.6 Key Developments

13.4 F. Hoffmann-La Roche Ltd

13.4.1 Key Facts

13.4.2 Business Description

13.4.3 Products and Services

13.4.4 Financial Overview

13.4.5 SWOT Analysis

13.4.6 Key Developments

13.5 Trinity Biotech Plc

13.5.1 Key Facts

13.5.2 Business Description

13.5.3 Products and Services

13.5.4 Financial Overview

13.5.5 SWOT Analysis

13.5.6 Key Developments

13.6 Danaher Corp

13.6.1 Key Facts

13.6.2 Business Description

13.6.3 Products and Services

13.6.4 Financial Overview

13.6.5 SWOT Analysis

13.6.6 Key Developments

13.7 Bio-Rad Laboratories Inc

13.7.1 Key Facts

13.7.2 Business Description

13.7.3 Products and Services

13.7.4 Financial Overview

13.7.5 SWOT Analysis

13.7.6 Key Developments

13.8 ACON Laboratories Inc

13.8.1 Key Facts

13.8.2 Business Description

13.8.3 Products and Services

13.8.4 Financial Overview

13.8.5 SWOT Analysis

13.8.6 Key Developments

13.9 DiaSorin SpA

13.9.1 Key Facts

13.9.2 Business Description

13.9.3 Products and Services

13.9.4 Financial Overview

13.9.5 SWOT Analysis

13.9.6 Key Developments

14. Appendix

14.1 About Us

14.2 Glossary of Terms

List of Tables

Table 1. North America Infectious Disease Diagnostics Market Segmentation

Table 2. Infectious Diseases and Fundings

Table 3. North America Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology - Revenue and Forecast to 2030 (US$ Million)

Table 4. North America Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology - Revenue and Forecast to 2030 (US$ Million)

Table 5. North America Infectious Disease Diagnostics Market, for Human Testing by Testing Type - Revenue and Forecast to 2030 (US$ Million)

Table 6. US: North America Infectious Disease Diagnostics Market, by Product - Revenue and Forecast to 2030 (US$ Million)

Table 7. US: North America Infectious Disease Diagnostics Market, by Technology - Revenue and Forecast to 2030 (US$ Million)

Table 8. US North America Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology - Revenue and Forecast to 2030 (US$ Million)

Table 9. US: North America Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology - Revenue and Forecast to 2030 (US$ Million)

Table 10. US: North America Infectious Disease Diagnostics Market, by Application Type - Revenue and Forecast to 2030 (US$ Million)

Table 11. US: North America Infectious Disease Diagnostics Market, by Testing Type - Revenue and Forecast to 2030 (US$ Million)

Table 12. US: North America Infectious Disease Diagnostics Market, for Human Testing by Testing Type - Revenue and Forecast to 2030 (US$ Million)

Table 13. US: North America Infectious Disease Diagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million)

Table 14. Canada: North America Infectious Disease Diagnostics Market, by Product - Revenue and Forecast to 2030 (US$ Million)

Table 15. Canada: North America Infectious Disease Diagnostics Market, by Technology - Revenue and Forecast to 2030 (US$ Million)

Table 16. Canada: North America Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology - Revenue and Forecast to 2030 (US$ Million)

Table 17. Canada: North America Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology - Revenue and Forecast to 2030 (US$ Million)

Table 18. Canada: North America Infectious Disease Diagnostics Market, by Application Type - Revenue and Forecast to 2030 (US$ Million)

Table 19. Canada: North America Infectious Disease Diagnostics Market, by Testing Type - Revenue and Forecast to 2030 (US$ Million)

Table 20. Canada: North America Infectious Disease Diagnostics Market, for Human Testing by Testing Type - Revenue and Forecast to 2030 (US$ Million)

Table 21. Canada: North America Infectious Disease Diagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million)

Table 22. Mexico: North America Infectious Disease Diagnostics Market, by Product - Revenue and Forecast to 2030 (US$ Million)

Table 23. Mexico: North America Infectious Disease Diagnostics Market, by Technology - Revenue and Forecast to 2030 (US$ Million)

Table 24. Mexico: North America Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology - Revenue and Forecast to 2030 (US$ Million)

Table 25. Mexico: North America Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology - Revenue and Forecast to 2030 (US$ Million)

Table 26. Mexico: North America Infectious Disease Diagnostics Market, by Application Type - Revenue and Forecast to 2030 (US$ Million)

Table 27. Mexico: North America Infectious Disease Diagnostics Market, by Testing Type - Revenue and Forecast to 2030 (US$ Million)

Table 28. Mexico: North America Infectious Disease Diagnostics Market, for Human Testing by Testing Type - Revenue and Forecast to 2030 (US$ Million)

Table 29. Mexico: North America Infectious Disease Diagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million)

Table 30. Organic Developments Done By Companies

Table 31. Inorganic Developments Done By Companies

Table 32. Glossary of Terms, North America Infectious Disease Diagnostics Market

List of Figures

Figure 1. North America Infectious Disease Diagnostics Market Segmentation, By Country

Figure 2. North America Infectious Disease Diagnostics Market - Key Industry Dynamics

Figure 3. Impact Analysis of Drivers and Restraints

Figure 4. North America Infectious Disease Diagnostics Market Revenue (US$ Mn), 2022 - 2030

Figure 5. North America Infectious Disease Diagnostics Market Revenue Share, by Product, 2022 & 2030 (%)

Figure 6. Kits & Reagents: North America Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)

Figure 7. Instruments: North America Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)

Figure 8. Software & Services: North America Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)

Figure 9. North America Infectious Disease Diagnostics Market Revenue Share, by Technology, 2022 & 2030 (%)

Figure 10. Biosensor-based: North America Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)

Figure 11. Immunodiagnostics: North America Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)

Figure 12. Molecular-Based Diagnostic Techniques: North America Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)

Figure 13. Clinical Biology: North America Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)

Figure 14. Others: North America Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)

Figure 15. North America Infectious Disease Diagnostics Market Revenue Share, by Application Type, 2022 & 2030 (%)

Figure 16. Point-of-Care Testing: North America Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)

Figure 17. Laboratory Testing: North America Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)

Figure 18. North America Infectious Disease Diagnostics Market Revenue Share, by Testing Type, 2022 & 2030 (%)

Figure 19. Human Testing: North America Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)

Figure 20. Veterinary Testing: North America Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)

Figure 21. North America Infectious Disease Diagnostics Market Revenue Share, by End User, 2022 & 2030 (%)

Figure 22. Diagnostic Laboratories: North America Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)

Figure 23. Hospitals and Clinics: North America Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)

Figure 24. Research Institutes: North America Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)

Figure 25. Homecare Settings: North America Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)

Figure 26. Others: North America Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)

Figure 27. North America: Infectious Disease Diagnostics Market, by Key Country - Revenue (2022) (US$ Million)

Figure 28. North America Infectious Disease Diagnostics Market, By Key Countries, 2022 and 2030 (%)

Figure 29. US: North America Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)

Figure 30. Canada: North America Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)

Figure 31. Mexico: North America Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)

Figure 32. Growth Strategies Done by the Companies in the Market, (%)